Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
Eric G. Meissner,Moti Ramgopal,Peter J. Ruane,William Sanchez,Gordon E. Crofoot,Jean-Pierre Routy,Cynthia Brinson,Edwin DeJesus,Claudia Martorell,Marcus Tellez,Yoshiyuki Yokomaku,Mark O’Reilly,Sergio Lupo,Sven Schellberg,Jezer Lezama-Mora,BumSik Chin,Keith Aizen,Michelle L. D’Antoni,Hailin Huang,Kwad Mponponsuo
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
Kao
cdercder
Nole
OK
无极微光
GingerF
Nexus
Criminology34
小小
伶俐妙海
柏柏
iNk
爱听歌的谷秋
sagitar
yjh123
小透明
arniu2008
Fellow_Lee
东方元语
皖公网安备34019202002308
